Pharmaceutical Supply – Sumatriptan Succinate Injection

The contract encompasses the supply and delivery of Sumatriptan Succinate Injection with NDC 68462-149-54, a commercial pharmaceutical product mandated to meet federal acquisition regulation standards FAR 52.212-4 and FAR 52.212-5. It includes full packaging and labeling requirements, ensuring regulatory compliance and product integrity throughout the supply chain. Traceable shipping protocols are required to maintain accountability from manufacturing to final delivery, which must be completed at a government-designated location. The effort is classified as a subcontract under the NAICS code 325412, indicating its focus on pharmaceutical and medicinal manufacturing. The contracting entity is the Defense Logistics Agency under the Department of Defense, with the solicitation posted on August 5, 2026. While no specific place of performance or point of contact is detailed, the contract is administered through the DIBBS system under the award identifier SPE2DX25D9822 and delivery identifier SPE2D226F3194. The contract does not specify a set-aside type or organization type, reflecting its standard commercial procurement nature under federal supply channels. All activities must adhere to government procurement protocols without exception, ensuring timely, secure, and fully documented fulfillment.